Pharmacokinetics of Treprostinil Diolamine in Subjects With End-Stage Renal Disease On or Off DialysisJENKINS, Amanda; WANG-SMITH, Laurene; MARBURY, Thomas et al.Journal of cardiovascular pharmacology. 2013, Vol 61, Num 4, pp 272-276, issn 0160-2446, 5 p.Article

Lack of a Pharmacokinetic Interaction Between Treprostinil Diolamine and Sildenafil in Healthy Adult VolunteersGOTZKOWSKY, S. Karl; KUMAR, Parag; MOTTOLA, David et al.Journal of cardiovascular pharmacology. 2013, Vol 61, Num 5, pp 444-451, issn 0160-2446, 8 p.Article

Efficacy and Safety of Oral Treprostinil Monotherapy for the Treatment of Pulmonary Arterial Hypertension: A Randomized, Controlled TrialJING, Zhi-Cheng; PARIKH, Keyur; ARNESON, Carl et al.Circulation (New York, N.Y.). 2013, Vol 127, Num 5, pp 624-633, issn 0009-7322, 10 p.Article

Oral Treprostinil for the Treatment of Pulmonary Arterial Hypertension in Patients on Background Endothelin Receptor Antagonist and/or Phosphodiesterase Type 5 Inhibitor Therapy (The FREEDOM-C Study): A Randomized Controlled TrialTAPSON, Victor F; TORRES, Fernando; SIGMAN, Jeffrey et al.Chest (American College of Chest Physicians). 2012, Vol 142, Num 6, pp 1383-1390, issn 0012-3692, 8 p.Article

Pharmacokinetics of Oral Treprostinil Sustained Release Tablets During Chronic Administration to Patients with Pulmonary Arterial HypertensionJAMES WHITE, R; TORRES, Fernando; ALLEN, Roblee et al.Journal of cardiovascular pharmacology. 2013, Vol 61, Num 6, pp 474-481, issn 0160-2446, 8 p.Article